TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/05/2024
Voltar para busca
Dado oficial do USPTO
GALVANI BIOELECTRONICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
24/05/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9
Data de depósito
27/02/2017
Data de registro
29/08/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/01/2024
Última transação
24/05/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
701
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
5
Tipo de titular
05
Localização do titular
Stevenage, GB
Examinador
DEFORD, JEFFREY
Unidade examinadora
M60
Localização atual
TMO LAW OFFICE 115
Descrição da marca
The mark consists of the wording "GALVANI BIOELECTRONICS" in stylized form, the word "BIOELECTRONICS" appears in smaller capital block letters below "GALVANI" and between the middle of the first letter "A" and "I" in "GALVANI".
Titulares e representantes
Titulares
GALVANI BIOELECTRONICS LIMITED
Glaxo Group Limited
Representantes
Christopher M. Hanes GSK
Classificação técnica
Classes Nice
Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Scientific measuring and monitoring apparatus and instrumentsmedical laboratory research instruments for DNA sequencingprotein characterizationfor the development of medical treatments that employ electrical impulse technology; bioelectronic instrumentssystems and devicessensorsarrays and nanoelectronicbiomolecular and nanodelivery devices for the delivery of therapeutic electrical impulses for research or scientific purposes; microchips for real-time signal processing; nanotechnological devices for harvesting energy to power micro-devicesnanoelectronicbiomolecular and nanodelivery devices; electrodescomputer chips and transistors; devices for biomedical applicationdevices for delivery of therapeutic electrical impulses for research or scientific purposes; computer software for processing biological data; apparatus for use in biotechnology and bioelectronicssensorsarrays and nanoelectronicbiomolecular and nanodelivery devices for the delivery of therapeutic electrical impulses for research or scientific purposes; instrumentssystems and devices for laboratorybioelectronic and clinical diagnosisresearch and analysisdiagnostic apparatus for the development of medical treatments that employ electrical impulse technology for research or scientific purposes; accessory devices for one or more of chargingdata storagedata transferdata analysiscomputer hardware; computer software for controlling medicalelectromedical and biomedical apparatus or equipment; computer software for processing medicalelectromedical and biomedical apparatus or equipment; computer software for processing medicalelectromedical and biomedical apparatus or equipment; biological analysis systems comprised of computer hardware and peripheralsin-vivo measurement and analysis measuring systems and bio-chips for research or scientific purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/05/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
16/01/2024
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
16/01/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/01/2024
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
28/11/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/11/2023
ES8R
TEAS SECTION 8 RECEIVED
16/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/09/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
23/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
23/09/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
29/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/12/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
15/05/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
18/04/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
29/08/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/06/2017
PUBO
PUBLISHED FOR OPPOSITION
13/06/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/05/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/05/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
05/05/2017
ALIE
ASSIGNED TO LIE
05/05/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/05/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
05/05/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/05/2017
DOCK
ASSIGNED TO EXAMINER
04/05/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2017
NWAP
NEW APPLICATION ENTERED
02/03/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GALVANI BIOELECTRONICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.